MURGF - Munich RE: Peak Valuation, Little Clear Upside

2025-01-29 18:10:08 ET

Summary

• Munich RE remains overvalued at just over €530/share, with a revised price target of €370/share due to slight improvements in future earnings expectations.
• The reinsurance industry faces headwinds, and Munich RE's diversification and ERGO segment pose risks, limiting the upside potential.
• Despite strong fundamentals and a conservative approach, Munich RE's yield and potential have dropped, making it less attractive for market outperformance. I consider the company to be a "HOLD" here.

Dear readers/followers,

During my last article on Munich RE ( MURGY ), I sold my remaining shares in the company in favor of other investments that have seen a solid upside. MURGY, by comparison, has not seen the same upside. The company was valued at close to €480/share last I wrote about it, and as I am writing here, that is still the price that we more or less are expected to pay for the business (some changes, up to just over €530).

My previous price target on the company was €365/share. Due to better-expected earnings as of 3Q24 and the company's future upside, I am actually going ahead and increasing my price target for the company here, but not by much - €5/share increase should in my view be sufficient to reflect this....

For further details see: